Regions Financial Corp Bio Techne Corp Transaction History

Regions Financial Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 25, 2022	SELL	$322.67 - $449.65 $175,532 - $244,609	-544 Closed	0 $0
Q4 2021 Jan 31, 2022	SELL	$456.15 - $525.06 $10,491 - $12,076	-23 Reduced 4.06%	544 $281,000
Q3 2021 Nov 04, 2021	BUY	$444.87 - $538.88 $4,448 - $5,388	10 Added 1.8%	567 $275,000
Q2 2021 Jul 27, 2021	BUY	$387.35 - $450.26 $215,753 - $250,794	557 New	557 $250,000
Q2 2019 Jul 19, 2019	SELL	$188.72 - $215.43 $13,587 - $15,510	-72 Closed	0 $0
Q1 2018 Apr 18, 2018	SELL	$131.46 - $151.04 $30,104 - $34,588	-229 Reduced 76.08%	72 $11,000
Q4 2017 Jan 18, 2018	BUY	$121.17 - $134.75 $36,472 - $40,559	301	301 $39,000

602

151M

195K

53.2K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.87B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Regions Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Regions Financial Corp with notifications on news.